Helping You to Uncover Mechanistic Hypotheses to Progress to the Clinic
Case study: Phosphorylation status determines kinase inhibitor binding
April 28, 2021: A new case study is presented going in-depth on [...]
Kinase inhibitor profiling and resistance mechanisms presented at the AACR Annual Meeting 2021
April 8, 2021: NTRC will present two scientific posters at the virtual [...]
TDO is a novel therapeutic target for Parkinson’s disease
February 22, 2021: A new article on the pharmacological validation of TDO [...]
PREMIUM BENEFITS OF NTRC ONCOLOGY PRECISION MEDICINE: Biochemical Assays, Drug-Target Interactions, Mechanistic Understanding
Screening services to find compounds with the best structure activity relationship
Determination of kinetic and activity-based selectivity
Differentiation of compounds by binding on- and off-rates
Biochemical and cell-based profiling under one roof
Science driven technology platforms like ResidenceTimer™
Short turnaround times: gain access to your data in weeks, not months
